Skip to content

Ensysce Biosciences, Inc.

ENSC ENSCW

CIK 0001716947

← back to feed
Revenue (TTM)
$4.15M
−2.8% YoY Q1 May 2026
Net Income (TTM)
−$18.24M
+503.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.99
+65.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-265.9%
Q1 May 2026
Net Margin
-440.0%
Q1 May 2026
Free Cash Flow (TTM)
−$12.35M
Q1 May 2026
Cash
$745.48K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
14.69M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings